Kirsten Leute Joins Osage University Partners as Senior VP of University Relations

kirsten-leuteOsage University Partners, a member of a family of investment funds developed by Osage Partners, hired Kirsten Leute as Senior Vice President of University Relations.

Leute previously was Associate Director of the Office of Technology Licensing at Stanford University. During her 18 years at Stanford, she was involved in numerous university spinouts and focused on licensing transactions across the biotechnology and physical sciences sectors. Leute has also held a number of senior leadership positions in the Association of University Technology Managers (AUTM). She is AUTM’s current Vice President for Membership, Western Hemisphere, and previously served as its Vice President for Communications. Leute holds a B.A. in the Biological Sciences from Wellesley College, an M.B.A. from Santa Clara University and is a registered U.S. Patent Agent.

She will work in Osage’s Bala Cynwyd headquarters outside of Philadelphia.

Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research managing the co-investment rights held by its affiliated universities and research institutions.
These co-investment rights provide Osage with contractual access to invest in the future financing rounds of promising startup companies that have licensed technology from affiliated institutions. In return for partnering with Osage, the participating institutions also share in the fund’s profit and can use their proceeds to stimulate further education, research, and commercialization initiatives.

The fund has invested in over 45 companies to date and its portfolio includes companies developing a range of products from therapeutics, medical devices, and diagnostics to energy, advanced materials, semiconductors, and software. It has enjoyed several exits including Aerie Pharmaceuticals, AGTC, Avid Radiopharmaceuticals, Immune Design, Otonomy and Receptos.

FinSMEs

28/08/2015

Join the discussion